COHANCE LIFESCIENCES
Back to Balance Sheet
|
COHANCE LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹53 Cr | ₹58 Cr | ₹18 Cr | ₹6.07 Cr | ₹6.07 Cr |
What is the latest Contingent Liabilities ratio of COHANCE LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹53 Cr |
| Mar2025 | ₹58 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹6.07 Cr |
| Mar2022 | ₹6.07 Cr |
How is Contingent Liabilities of COHANCE LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹53 Cr | -7.96 | |
| Mar2025 | ₹58 Cr | 219.82 | |
| Mar2024 | ₹18 Cr | 198.50 | |
| Mar2023 | ₹6.07 Cr | 0.00 | |
| Mar2022 | ₹6.07 Cr | - | |
Compare Contingent Liabilities of peers of COHANCE LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| COHANCE LIFESCIENCES | ₹16,840.1 Cr | -7.7% | -2.5% | -47.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹425,150.0 Cr | 0.8% | -2.1% | 4.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹266,265.0 Cr | 4.9% | 7.9% | 54.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹176,300.0 Cr | 1.6% | -2.7% | 28.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,351.0 Cr | 2.6% | 14.2% | 3.9% | Stock Analytics | |
| CIPLA | ₹112,474.0 Cr | 2.4% | 3.4% | -12% | Stock Analytics | |
COHANCE LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| COHANCE LIFESCIENCES | -7.7% |
-2.5% |
-47.7% |
| SENSEX | 4.5% |
6.1% |
-9.3% |
You may also like the below Video Courses